To support the development of next-gen therapies, including GLP-1 drugs for diabetes and obesity.

The future of manufacturing is not just about machines and AI; it's about re-empowering humans, according to a new study.

The Sound Shore Fund Investor Class (SSHFX) and Institutional Class (SSHVX) advanced 1.25% and 1.32%, respectively, in Q3 ...

Trump's tariffs will not only impact sponsors, but higher costs will ripple down the clinical trial supply chain in the US.

A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. | The FDA ...

Deborah McElhone, Head of Sustainability (Pharma) from CPI, argues that process intensification is a game changer for the ...

As SpringWorks Therapeutics nears a key regulatory decision in the U.S., the Connecticut-based cancer and rare disease ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

Roquette Reshapes the Pharmaceutical Coating Landscape with an Innovative and High-Performance Platform Lill ...

President Donald Trump signed an order Monday that imposes a 25% tariff on all steel imports to the United States.

China makes some of Americans’ most common medicines. They won’t be spared from Trump’s tariffs - Everyday painkillers, ...

India’s logistics sector is advancing rapidly, propelled by increasing investments, digital transformation, and robust policy ...